Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Rigid Bronchoscopy for Small Cell Lung Cancer Airway Stenosis

Academic abstract on therapeutic rigid bronchoscopy for airway stenosis caused by small cell lung cancer, with focus on urgent airway relief.

By Dr. Revathy Mohan V.R., MBBS · Oct 27, 2026 · 5 min read

Oncology·JNCI

Trastuzumab Deruxtecan ILD Risk Tied to Interstitial Lung Abnormalities

A JNCI study examines whether equivocal and definite interstitial lung abnormalities may raise the risk of trastuzumab deruxtecan-related…

Oct 27, 2026

Oncology·EHJ

Cutaneous T-cell lymphoma burden study centers on patients and care partners

An Oxford Academic abstract examines patient and care partner burden in cutaneous T-cell lymphoma using disease-specific symptom and…

Oct 27, 2026

Oncology·EHJ

Vimseltinib MOTION phase 3 long-term data in tenosynovial giant cell tumor

The scraped abstract title identifies long-term MOTION phase 3 results for vimseltinib in tenosynovial giant cell tumor, but…

Oct 27, 2026

Oncology·Lancet Onc

Rectal Cancer Trial: Short-Course RT Plus Camrelizumab Improves 3-Year EFS

UNION interim analysis found short-course radiotherapy plus camrelizumab and CAPOX improved 3-year event-free survival in locally advanced rectal…

Oct 27, 2026

Oncology·Lancet Onc

Alison Berner links oncology and gender medicine after transgender cancer gap

A 2015 Lancet Oncology editorial exposed the lack of cancer evidence in transgender people and helped steer Alison…

Oct 27, 2026

Oncology·Lancet Onc

Iberdomide enters the myeloma spotlight with enhanced cereblon potency

Iberdomide’s cereblon-binding design may deepen immunomodulation in multiple myeloma, with mechanistic relevance for minimal residual disease-negative disease.

Oct 27, 2026

Oncology·ACC-PRO

GSK B7-H3 ADC cuts osteosarcoma progression risk in phase 3 trial

Hansoh’s phase 3 Artemis-011 trial found GSK’s B7-H3 ADC improved progression-free survival in relapsed osteosarcoma versus chemotherapy.

Oct 27, 2026

Oncology·ACC-PRO

BMS and IHI Launch 3-Year Cancer Trial Access Partnership

Bristol Myers Squibb and IHI are launching a three-year effort to remove cancer trial barriers and raise breast…

Oct 27, 2026

Oncology·Lancet Onc

Daraxonrasib and the price barrier in pancreatic cancer care

Daraxonrasib delivered a survival gain in advanced pancreatic cancer, but the larger question is whether breakthrough drugs can…

Oct 27, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.